Skip to main content
. 2018 Oct 1;10:4051–4064. doi: 10.2147/CMAR.S174452

Table 5.

Comparison of the survival of colorectal cancer patients according to the nine-chemokine classifier in the combined training and validation set (n=492, GSE39582)

Set Risk group (n) Disease-free survival
Overall survival
1-year 3-year 5-year HR (95% CI) P-value 1-year 3-year 5-year HR (95% CI) P-value
The combined set (n=492) High-risk (n=111) 79.8% 55.6% 52.3% 2.383 <0.001 93.6% 77.1% 63.5% 1.603 0.010
Low-risk (n=381) 90.7% 79.6% 75.2% (1.690–3.359) 96.5% 85.2% 76.1% (1.115–2.305)